Agilent GenetiSure Dx Postnatal Assay

Agilent Technologies has launched the GenetiSure Dx Postnatal Assay. The assay uses the company's comparative genomic hybridization technology, which provides data on copy number variations and absence of heterozygosity. The test will help clinical labs implement cytogenetic testing, Agilent said.


Lexogen Quantitative RNA-Seq Service

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.